172 related articles for article (PubMed ID: 24374321)
1. Cotinine impacts sensory processing in DBA/2 mice through changes in the conditioning amplitude.
Wildeboer-Andrud KM; Zheng L; Choo KS; Stevens KE
Pharmacol Biochem Behav; 2014 Feb; 117():144-50. PubMed ID: 24374321
[TBL] [Abstract][Full Text] [Related]
2. Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism.
Wildeboer KM; Zheng L; Choo KS; Stevens KE
Brain Res; 2009 Dec; 1300():41-50. PubMed ID: 19728991
[TBL] [Abstract][Full Text] [Related]
3. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism.
Simosky JK; Stevens KE; Adler LE; Freedman R
Psychopharmacology (Berl); 2003 Feb; 165(4):386-96. PubMed ID: 12459928
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine improves deficient sensory inhibition in DBA/2 mice.
Simosky JK; Freedman R; Stevens KE
Brain Res; 2008 Oct; 1233():129-36. PubMed ID: 18687314
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice.
Wildeboer KM; Stevens KE
Brain Res; 2008 Aug; 1224():29-36. PubMed ID: 18582447
[TBL] [Abstract][Full Text] [Related]
6. Acute administration of Δ⁹ tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice.
Smucny J; Stevens KE; Tregellas JR
Pharmacol Biochem Behav; 2014 Mar; 118():22-9. PubMed ID: 24418217
[TBL] [Abstract][Full Text] [Related]
7. Effects of the novel α7 nicotinic acetylcholine receptor agonist ABT-107 on sensory gating in DBA/2 mice: pharmacodynamic characterization.
Radek RJ; Robb HM; Stevens KE; Gopalakrishnan M; Bitner RS
J Pharmacol Exp Ther; 2012 Dec; 343(3):736-45. PubMed ID: 22988063
[TBL] [Abstract][Full Text] [Related]
8. Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice.
Simosky JK; Stevens KE; Kem WR; Freedman R
Biol Psychiatry; 2001 Oct; 50(7):493-500. PubMed ID: 11600102
[TBL] [Abstract][Full Text] [Related]
9. Intermittent versus continuous central administration of clozapine in DBA/2 mice, improvement in sensory inhibition deficits.
Stevens KE; Zheng L; Abrams DJ
Schizophr Res; 2013 Sep; 149(1-3):121-6. PubMed ID: 23863771
[TBL] [Abstract][Full Text] [Related]
10. Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating.
Radek RJ; Miner HM; Bratcher NA; Decker MW; Gopalakrishnan M; Bitner RS
Psychopharmacology (Berl); 2006 Jul; 187(1):47-55. PubMed ID: 16767415
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicotine vary across two auditory evoked potentials in the mouse.
Metzger KL; Maxwell CR; Liang Y; Siegel SJ
Biol Psychiatry; 2007 Jan; 61(1):23-30. PubMed ID: 16497274
[TBL] [Abstract][Full Text] [Related]
12. Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.
Stevens KE; Zheng L; Floyd KL; Stitzel JA
Brain Res; 2015 Jun; 1611():8-17. PubMed ID: 25744161
[TBL] [Abstract][Full Text] [Related]
13. Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials.
Featherstone RE; Phillips JM; Thieu T; Ehrlichman RS; Halene TB; Leiser SC; Christian E; Johnson E; Lerman C; Siegel SJ
PLoS One; 2012; 7(7):e39775. PubMed ID: 22911690
[TBL] [Abstract][Full Text] [Related]
14. Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.
Stevens KE; Choo KS; Stitzel JA; Marks MJ; Adams CE
Brain Res; 2014 Mar; 1552():26-33. PubMed ID: 24462939
[TBL] [Abstract][Full Text] [Related]
15. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.
Stevens KE; Kem WR; Mahnir VM; Freedman R
Psychopharmacology (Berl); 1998 Apr; 136(4):320-7. PubMed ID: 9600576
[TBL] [Abstract][Full Text] [Related]
16. Permanent improvement in deficient sensory inhibition in DBA/2 mice with increased perinatal choline.
Stevens KE; Adams CE; Yonchek J; Hickel C; Danielson J; Kisley MA
Psychopharmacology (Berl); 2008 Jun; 198(3):413-20. PubMed ID: 18446322
[TBL] [Abstract][Full Text] [Related]
17. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
Siegel SJ; Maxwell CR; Majumdar S; Trief DF; Lerman C; Gur RE; Kanes SJ; Liang Y
Neuroscience; 2005; 133(3):729-38. PubMed ID: 15908134
[TBL] [Abstract][Full Text] [Related]
18. Effects of phencyclidine on auditory gating in the rat hippocampus and the medial prefrontal cortex.
Dissanayake DW; Zachariou M; Marsden CA; Mason R
Brain Res; 2009 Nov; 1298():153-60. PubMed ID: 19699183
[TBL] [Abstract][Full Text] [Related]
19. Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors.
Hashimoto K; Iyo M; Freedman R; Stevens KE
Psychopharmacology (Berl); 2005 Nov; 183(1):13-9. PubMed ID: 16136299
[TBL] [Abstract][Full Text] [Related]
20. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
Feuerbach D; Lingenhoehl K; Olpe HR; Vassout A; Gentsch C; Chaperon F; Nozulak J; Enz A; Bilbe G; McAllister K; Hoyer D
Neuropharmacology; 2009 Jan; 56(1):254-63. PubMed ID: 18793655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
